EUVIMEDEUVIMED entdecken
Crossref

Triphenylphosphine-Modified Iridium III , Rhodium III , and Ruthenium II Complexes to Achieve Enhanced Anticancer Selectivity by Targeting Mitochondria

Zhe Liu iD, Hanxiu Fu, Heqian Dong, Kangning Lai, Zhihao Yang, Chunyan Fan, Yuting Luo, Wenting Qin, Lihua Guo iD

Inorganic Chemistry · 30.12.2024 · 63 (52) · 24736-24753

DOI: 10.1021/acs.inorgchem.4c03975 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Inorganic Chemistry, online erschienen am 16.12.2024. Verfasst von Zhe Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Life-Organic Analysis of Shandong Province, Key Laboratory of Green Natural Products and Pharmaceutical Intermediates in Colleges a…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Mitochondria, Coordination Complexes, Organophosphorus Compounds. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 98 Literaturangaben. Gefördert von: Taishan Scholar Project of Shandong Province, Natural Science Foundation of Shandong Province, Young Talents Invitation Program of Shandong Provincial Colleges and Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The incorporation of an organelle-targeting moiety into compounds has proven to be an effective strategy in the development of targeted anticancer drugs. We herein report the synthesis, characterization, and biological evaluation of novel triphenylphosphine-modified half-sandwich iridiumIII, rhodiumIII, and rutheniumII complexes. The primary goal was to enhance anticancer selectivity through mitochondrial targeting. All these triphenylphosphine-modified complexes exhibited promising cytotoxicity in the micromolar range (5.13-23.22) against A549 and HeLa cancer cell lines, surpassing the activity of comparative complexes that lack the triphenylphosphine moiety. Noteworthy is their good selectivity toward cancer cells compared to normal BEAS-2B cells, underscored by selectivity index ranging from 7.3 to >19.5. Mechanistically, these complexes primarily target mitochondria rather than interacting with DNA. The targeting of mitochondria and triggering mitochondrial dysfunction were confirmed using both confocal microscopy and flow cytometry. Their ability to depolarize mitochondrial membrane potential (MMP) and enhance reactive oxygen species (ROS) was observed, thereby leading to intrinsic apoptotic pathways. Moreover, these complexes lead to cell cycle arrest in the G2/M phase and demonstrated antimigration effects, significantly inhibiting the migration of A549 cells in wound-healing assays.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsMitochondriaCoordination ComplexesOrganophosphorus CompoundsRutheniumHumansIridiumRhodiumDrug Screening Assays, AntitumorMembrane Potential, MitochondrialReactive Oxygen SpeciesApoptosisCell ProliferationHeLa CellsMolecular StructureA549 CellsStructure-Activity Relationship

Substanzen

Antineoplastic AgentstriphenylphosphineIridiumCoordination ComplexesRhodiumOrganophosphorus CompoundsRutheniumReactive Oxygen Species

Autor:innen und Institutionen

  • Key Laboratory of Life-Organic Analysis of Shandong Province, Key Laboratory of Green Natural Products and Pharmaceutical Intermediates in Colleges and Universities of Shandong Province, School of Chemistry and Chemical…

ORCID-Profile: Zhe Liu, Lihua Guo

Förderung

  • Taishan Scholar Project of Shandong Province
  • Natural Science Foundation of Shandong Province
  • Young Talents Invitation Program of Shandong Provincial Colleges and Universities

Zitieren

APA

Liu, Z., Fu, H., Dong, H., Lai, K., Yang, Z., Fan, C., Luo, Y., Qin, W., & Guo, L. (2024). Triphenylphosphine-Modified Iridium III , Rhodium III , and Ruthenium II Complexes to Achieve Enhanced Anticancer Selectivity by Targeting Mitochondria. Inorganic Chemistry, 63(52), 24736-24753. https://doi.org/10.1021/acs.inorgchem.4c03975

Vancouver

Liu Z, Fu H, Dong H, Lai K, Yang Z, Fan C, et al. Triphenylphosphine-Modified Iridium III , Rhodium III , and Ruthenium II Complexes to Achieve Enhanced Anticancer Selectivity by Targeting Mitochondria. Inorganic Chemistry. 2024;63(52):24736-24753. doi:10.1021/acs.inorgchem.4c03975

BibTeX
@article{Liu2024,
  author = {Liu, Zhe and Fu, Hanxiu and Dong, Heqian and Lai, Kangning and Yang, Zhihao and Fan, Chunyan and Luo, Yuting and Qin, Wenting and Guo, Lihua},
  title = {Triphenylphosphine-Modified Iridium III , Rhodium III , and Ruthenium II Complexes to Achieve Enhanced Anticancer Selectivity by Targeting Mitochondria},
  journal = {Inorganic Chemistry},
  year = {2024},
  volume = {63},
  number = {52},
  pages = {24736--24753},
  doi = {10.1021/acs.inorgchem.4c03975}
}
Kostenlos starten →